ExploreWatchlistsPricing
  1. JP-listed companies
  2. Kubota Pharmaceutical Holdings Co., Ltd.
  3. Financials
  4. Retained earnings

Kubota Pharmaceutical Holdings Co., Ltd. (4596)

Market cap
¥11.2B
P/E ratio
Kubota Pharmaceutical develops innovative eye disease treatments including wearable myopia devices and pharmaceuticals for conditions like diabetic retinopathy.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Dec 31, 2025-25,733+2.70%
Dec 31, 2024-25,057-2.39%
Dec 31, 2023-25,670+6.16%
Dec 31, 2022-24,181+9.10%
Dec 31, 2021-22,165+13.38%
Dec 31, 2020-19,548+14.24%
Dec 31, 2019-17,111+1255.20%
Dec 31, 2018-1,263+37.18%
Dec 31, 2017-920+90.01%
Dec 31, 2016-484+69796.83%
Dec 31, 2015-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat